logo

Exhibiting at VIV Asia 2025

2-3710
Bangkok
12 Mar - 14 Mar, 2025

Product Offerings

Products:

Nutri: Feed additives and supplements for livestock nutrition

Pharma: Veterinary pharmaceutical products

Hi-Tech: Technological solutions for animal health

Umana: Food safety products

About Dox-al Italia S.p.A.

Dox-al Italia S.p.A. is a leading manufacturer of veterinary pharmaceuticals, feed additives, and food safety solutions, headquartered in Sulbiate, Italy. With a strong scientific foundation and decades of experience, Dox-al focuses on animal nutrition, health, and welfare, ensuring sustainable and innovative solutions for the livestock industry.

Dox-al Italia S.p.A. operates in over 60 countries, providing cutting-edge veterinary products and feed supplements that enhance animal performance, disease prevention, and food safety.

Core Business and Specialization

Dox-al specializes in integrated solutions for animal health and nutrition, offering high-performance feed additives, pharmaceuticals, and biosecurity products.

Product Portfolio:

  • Nutri (Animal Nutrition Solutions)

    • Specialized feed additives and supplements designed to improve livestock productivity and health.
    • Probiotics and prebiotics to enhance gut health and digestion.
    • Essential vitamins, minerals, and amino acids to optimize growth and performance.
  • Pharma (Veterinary Pharmaceuticals)

    • Antibiotics, anti-inflammatories, and antiparasitic drugs for livestock health management.
    • Oral and injectable veterinary medicines for poultry, swine, ruminants, and aquaculture.
  • Hi-Tech (Advanced Technological Solutions for Animal Health)

    • Encapsulated bioactive compounds for controlled release of essential nutrients.
    • Microencapsulation technology to enhance stability and bioavailability of feed additives.
  • Umana (Food Safety Products)

    • Biosecurity and hygiene products for livestock farming and food production.
    • Solutions for controlling mycotoxins, pathogens, and harmful residues in animal feed and food processing.

Dox-al’s products are backed by rigorous scientific research, ensuring efficacy, safety, and compliance with international standards.

Manufacturing and Capabilities

Dox-al Italia S.p.A. operates state-of-the-art manufacturing facilities, equipped with advanced formulation technologies to ensure high-quality and precision-engineered veterinary products.

Key Manufacturing Strengths:

  • GMP-certified production facilities, ensuring pharmaceutical-grade feed additives and veterinary drugs.
  • Advanced microencapsulation technology, improving stability and absorption of nutrients.
  • Stringent quality control measures, maintaining high standards for safety and efficacy.
  • Continuous investment in R&D, driving innovation in animal health and nutrition.

Dox-al’s manufacturing excellence ensures that its products meet global safety and efficacy requirements.

International Market Presence and Export

Dox-al Italia S.p.A. is a key player in the global animal health industry, exporting high-quality feed additives and veterinary products to over 60 countries.

Export Data:

  • Major Export Destinations: Europe, Asia, Middle East, Africa, and Latin America.
  • Key Exported Products: Encapsulated nutrients, veterinary pharmaceuticals, and food safety solutions.
  • Distribution Network: Partnerships with veterinary distributors, feed manufacturers, and agribusinesses worldwide.
  • Annual Export Volume: Thousands of metric tons of specialized animal health and nutrition products shipped globally.

Dox-al’s strong distribution and supply chain infrastructure ensures timely and reliable delivery across international markets.

Financial Strength and Performance

Dox-al Italia S.p.A. continues to experience consistent financial growth, driven by rising demand for high-quality veterinary pharmaceuticals and feed solutions.

Key Financial Highlights:

  • Steady revenue growth, fueled by expanding global market presence.
  • Investment in R&D, focusing on next-generation probiotics, biosecurity solutions, and encapsulation technology.
  • Expansion into new markets, securing a strong foothold in emerging economies.

Dox-al’s financial stability and commitment to innovation position it as a global leader in veterinary health and nutrition.

Certifications and Compliance

Dox-al Italia S.p.A. maintains strict compliance with international veterinary health and food safety regulations, ensuring safe, effective, and high-quality products.

Key Certifications:

  • GMP (Good Manufacturing Practices) Certification – Ensuring pharmaceutical-grade production of feed additives and veterinary drugs.
  • FAMI-QS Certification – Compliance with EU feed safety regulations for safe and high-quality feed additives.
  • ISO 9001: Quality Management System Certification – Guaranteeing consistent quality control.
  • HACCP Compliance – Ensuring food safety across the supply chain.

These certifications reflect Dox-al’s commitment to safety, sustainability, and scientific excellence.

Major Achievements

  • Expanded global presence, supplying veterinary pharmaceuticals and feed solutions to over 60 countries.
  • Developed proprietary encapsulation technology, improving nutrient absorption in livestock feed.
  • Recognized as an industry leader in feed additives and biosecurity solutions.
  • Strengthened partnerships with global agribusinesses and veterinary research institutions, driving product innovation and market expansion.

Customer Testimonials

Dox-al Italia S.p.A. is trusted by veterinarians, livestock farmers, and feed manufacturers for its scientific approach and high-quality solutions.

  • “THEPAX® probiotic formulations have significantly improved gut health in our poultry farms.”
  • “Dox-al’s microencapsulated feed additives ensure better nutrient absorption and animal performance.”
  • “GREENDOX® natural antioxidant blends have enhanced livestock immunity and overall health.”

Future Outlook

Dox-al Italia S.p.A. continues to invest in innovative solutions, focusing on next-generation animal health and nutrition technologies.

Future Plans:

  • Expanding R&D efforts, developing new probiotics, encapsulated bioactives, and antibiotic-free solutions.
  • Strengthening international partnerships, increasing market penetration in emerging economies.
  • Enhancing sustainability initiatives, focusing on eco-friendly feed solutions and reducing antibiotic dependence.
  • Investing in digital solutions, integrating precision livestock nutrition and data-driven feed management systems.

With a strong reputation for innovation, scientific excellence, and sustainability, Dox-al Italia S.p.A. remains a global leader in animal health and nutrition solutions, ensuring better animal welfare and sustainable food production for the future.